Clinical trial
CHUM-CRYOABLATION: Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers
NCT01856036 is registered in ClinicalTrials.gov with Saint John's Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CHUM-CRYOABLATION: Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers
- Lead sponsor
- Saint John's Cancer Institute
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2013
- Completion date
- October 31, 2014
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer